《非肌层浸润性膀胱癌患者的总液体摄入量与复发风险：一项前瞻性队列研究》勘误
Erratum to: Total Fluid Intake and the Risk of Recurrence in Patients with Non-Muscle Invasive Bladder Cancer: A Prospective Cohort Study.
作者信息
Jochems Sylvia H J, Wesselius Anke, Zeegers Maurice P
机构信息
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Department of Complex Genetics and Epidemiology, School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.
出版信息
Bladder Cancer. 2020 Sep 21;6(3):401. doi: 10.3233/BLC-200006.
Abstract
[This corrects the article DOI: 10.3233/BLC-180172.].
摘要
[本文更正了文章的数字对象标识符：10.3233/BLC-180172。]
相似文献
1
Erratum to: Total Fluid Intake and the Risk of Recurrence in Patients with Non-Muscle Invasive Bladder Cancer: A Prospective Cohort Study.《非肌层浸润性膀胱癌患者的总液体摄入量与复发风险：一项前瞻性队列研究》勘误
Bladder Cancer. 2020 Sep 21;6(3):401. doi: 10.3233/BLC-200006.
2
Total Fluid Intake and the Risk of Recurrence in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective Cohort Study.非肌层浸润性膀胱癌患者的总液体摄入量与复发风险：一项前瞻性队列研究。
Bladder Cancer. 2018 Jul 30;4(3):303-310. doi: 10.3233/BLC-180172.
3
Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?六亚甲基蓝（HAL）荧光膀胱镜检查后的治疗变化和长期复发率：对非肌肉浸润性膀胱癌（NMIBC）患者真的有影响吗？
BJU Int. 2012 Feb;109(4):549-56. doi: 10.1111/j.1464-410X.2011.10374.x. Epub 2011 Jun 28.
4
Utility of Blue Light Cystoscopy for Post-bacillus Calmette-Guérin Bladder Cancer Recurrence Detection: Implications for Clinical Trial Recruitment and Study Comparisons.蓝激光膀胱镜在卡介苗膀胱癌复发检测中的应用：对临床试验招募和研究比较的影响。
J Urol. 2022 Mar;207(3):534-540. doi: 10.1097/JU.0000000000002308. Epub 2021 Oct 25.
5
Fruit and vegetable intake and the risk of recurrence in patients with non-muscle invasive bladder cancer: a prospective cohort study.水果和蔬菜摄入量与非肌层浸润性膀胱癌患者的复发风险：一项前瞻性队列研究。
Cancer Causes Control. 2018 Jun;29(6):573-579. doi: 10.1007/s10552-018-1029-9. Epub 2018 Apr 17.
6
Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry.蓝光膀胱镜检查用于膀胱癌诊断：美国前瞻性多中心注册研究结果
Urol Oncol. 2018 Aug;36(8):361.e1-361.e6. doi: 10.1016/j.urolonc.2018.04.013. Epub 2018 May 30.
7
Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations.六氨基己酸光动力蓝激光膀胱镜检查的临床和成本效益：证据回顾和更新的专家建议。
Eur Urol. 2014 Nov;66(5):863-71. doi: 10.1016/j.eururo.2014.06.037. Epub 2014 Jul 4.
8
Erratum: Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer.勘误：三级淋巴结构与尿路上皮膀胱癌的肿瘤分期相关。
Bladder Cancer. 2018 Jan 20;4(1):137. doi: 10.3233/BLC-189029.
9
Contemporary cost-consequence analysis of blue light cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer.非肌层浸润性膀胱癌中使用六氨基乙酰丙酸进行蓝光膀胱镜检查的当代成本-后果分析。
Can Urol Assoc J. 2017 Jun;11(6):173-181. doi: 10.5489/cuaj.4568.
10
Effectiveness of hexaminolevulinate fluorescence cystoscopy for the diagnosis of non-muscle-invasive bladder cancer in daily clinical practice: a Spanish multicentre observational study.六氨基乙酰丙酸荧光膀胱镜检查在日常临床实践中诊断非肌层浸润性膀胱癌的有效性：一项西班牙多中心观察性研究。
BJU Int. 2015 Jul;116(1):37-43. doi: 10.1111/bju.13020. Epub 2015 Mar 25.
引用本文的文献
1
Fluid intake and recurrence and progression risk of patients with non-muscle-invasive bladder cancer.非肌层浸润性膀胱癌患者的液体摄入量与复发及进展风险
BJU Int. 2025 Sep;136(3):429-438. doi: 10.1111/bju.16665. Epub 2025 Jan 25.
本文引用的文献
1
Total Fluid Intake and the Risk of Recurrence in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective Cohort Study.非肌层浸润性膀胱癌患者的总液体摄入量与复发风险：一项前瞻性队列研究。
Bladder Cancer. 2018 Jul 30;4(3):303-310. doi: 10.3233/BLC-180172.
Zotero 插件